Butenophthalein and hemoceton are both used in patients with acute cerebral infarction, but their mechanism of action is different, and their combined application is more effective in the treatment of neurological deficits in patients with cerebral infarction. Butanephthalein is mainly used in the treatment of mild to moderate acute cerebral infarction, with the effect of improving cerebral metabolism, promoting the formation of collateral circulation, and scavenging of oxygen free radicals; Hexetone is a preparation of traditional Chinese medicine, and the main ingredient is the total saponins of Panax ginseng, which is mainly used to activate the blood circulation and remove blood stasis. Both drugs can be used in the treatment of cerebral infarction patients with neurological deficits, but due to butylphthalide and haemosiderophon protection of the brain mechanism is not exactly the same, the combination of the two for the treatment of acute ischemic cerebrovascular disease has a complementary efficacy, the relevant clinical research observations suggest that the joint use of drugs compared with the use of haemosiderophon can significantly improve the neurological function of the patient and the ability to live. However, patients with cerebral infarction, the specific condition is different, there are differences in the use of drugs, suitable for what drug treatment should listen to the advice of the competent doctor, not blindly use their own drugs, so as not to delay the condition.